找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Design and Discovery; Inhibitors of Mitoge Surya K. De Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive lice

[復制鏈接]
查看: 46817|回復: 37
樓主
發(fā)表于 2025-3-21 18:03:54 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug Design and Discovery
副標題Inhibitors of Mitoge
編輯Surya K. De
視頻videohttp://file.papertrans.cn/285/284830/284830.mp4
概述Describes role of small molecules in the modulation of MAPK pathways in the development of future medicine therapies.Analyzes recent challenges in designing small molecule inhibitors of MAP kinases.Pr
圖書封面Titlebook: Drug Design and Discovery; Inhibitors of Mitoge Surya K. De Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive lice
描述.This book covers the important role small molecules can play in the modulation of stress-activated protein kinase (SAPK), also called the mitogen-activated protein kinase (MAPK) pathway, and the potential this may offer in enabling the development of future medicine therapies. It is clear that MAP kinase pathway therapies could continue to drive increasing interest in the field, both within academic laboratories and also in the biotechnology and pharmaceutical sectors. This book provides an overview of protein kinase inhibitors, the biological roles of MAP kinases, ATP-competitive and non-competitive inhibitors, covalent inhibitors, and more. This book is intended for professors in academia, researchers in pharmaceutical and biotechnology sectors working on protein kinases, and graduate students in pharmacy/chemistry..
出版日期Book 2024
關鍵詞Protein Kinase Inhibitors; Drug Design; Drug Delivery; Mitogen-Activated Protein Kinase Inhibitors; Clin
版次1
doihttps://doi.org/10.1007/978-3-031-75682-5
isbn_softcover978-3-031-75684-9
isbn_ebook978-3-031-75682-5
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Drug Design and Discovery影響因子(影響力)




書目名稱Drug Design and Discovery影響因子(影響力)學科排名




書目名稱Drug Design and Discovery網(wǎng)絡公開度




書目名稱Drug Design and Discovery網(wǎng)絡公開度學科排名




書目名稱Drug Design and Discovery被引頻次




書目名稱Drug Design and Discovery被引頻次學科排名




書目名稱Drug Design and Discovery年度引用




書目名稱Drug Design and Discovery年度引用學科排名




書目名稱Drug Design and Discovery讀者反饋




書目名稱Drug Design and Discovery讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-22 00:02:29 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:38:08 | 只看該作者
Nathan B. Fountain,Fritz E. Dreifuss are in the market for the treatment of cancer and other diseases. Many research institutes discovered preclinical ATP-competitive inhibitors of MAP kinases using fragment-based drug design or optimization of their initial hit from high-throughput screening to improve in vitro potency only but lack
地板
發(fā)表于 2025-3-22 07:30:46 | 只看該作者
5#
發(fā)表于 2025-3-22 11:28:15 | 只看該作者
Excursus I: Values and Human Rights, specific target protein and effectively disrupt the activity of the target protein, which involve disease processes such as cancer progression, inflammatory responses, or infectious diseases. The reaction mechanisms of some FDA-approved covalent inhibitors are depicted. The binding mode of covalent
6#
發(fā)表于 2025-3-22 14:50:35 | 只看該作者
https://doi.org/10.1007/978-3-031-75682-5Protein Kinase Inhibitors; Drug Design; Drug Delivery; Mitogen-Activated Protein Kinase Inhibitors; Clin
7#
發(fā)表于 2025-3-22 20:00:24 | 只看該作者
8#
發(fā)表于 2025-3-23 00:30:09 | 只看該作者
9#
發(fā)表于 2025-3-23 05:27:37 | 只看該作者
10#
發(fā)表于 2025-3-23 09:20:20 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 02:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
茌平县| 延庆县| 定陶县| 湖北省| 安阳市| 新干县| 惠州市| 巩义市| 曲阳县| 宁津县| 定南县| 兴城市| 秦安县| 刚察县| 博白县| 洞头县| 建始县| 山西省| 乐东| 尉氏县| 福海县| 望江县| 科尔| 浦县| 阳江市| 晋中市| 云南省| 福鼎市| 岚皋县| 平泉县| 遂平县| 嘉黎县| 洪洞县| 南漳县| 海南省| 蓝田县| 南和县| 云和县| 越西县| 绥芬河市| 小金县|